Paradigm Capital Management Inc. NY acquired a new stake in Health Catalyst, Inc. (NASDAQ:HCAT – Get Rating) in the 4th quarter, according to its most recent disclosure with the SEC. The fund acquired 20,000 shares of the company’s stock, valued at approximately $213,000. Other hedge funds and other institutional investors have also recently added to […]
Wells Fargo & Company upgraded shares of Health Catalyst (NASDAQ:HCAT – Get Rating) from an equal weight rating to an overweight rating in a research report report published on Tuesday morning, MarketBeat.com reports. Wells Fargo & Company currently has $16.00 price target on the stock, up from their prior price target of $13.00. A number […]